Deal Roster: Bristol-myers Squibb, Amylin Pharmaceuticals
Leon Kalvaria led a Citigroup Inc. team that advised Bristol-Myers Squibb Co. on its proposed $5.3 billion takeover of Amylin Pharmaceuticals Inc., which is the drugmaker’s biggest acquisition since 2001.
The same team of bankers advised Bristol-Myers on the $2.1 billion takeover of Inhibitex Inc. completed in February. Francois Maisonrouge and Evercore Partners Inc. bankers were also hired to advise New York-based Bristol-Myers. This is the first time Evercore has consulted the company on mergers and acquisitions, according to Bloomberg data.